25343-30-0 Usage
Uses
Used in the Rubber Industry:
2,6-DIETHYLPHENYLTHIOUREA is used as a rubber accelerator for the production of vulcanized rubber. It facilitates the cross-linking of polymer chains, which is crucial for improving the mechanical properties and resilience of rubber products. The use of DETU in this application type is driven by its ability to accelerate the vulcanization process, thereby enhancing the overall quality and performance of rubber goods.
While the provided materials do not specify other industries where 2,6-DIETHYLPHENYLTHIOUREA might be used, its properties as a white crystalline solid soluble in organic solvents could potentially make it suitable for other applications where similar characteristics are beneficial. However, without additional context or information, it is not possible to list further uses for 2,6-DIETHYLPHENYLTHIOUREA.
Check Digit Verification of cas no
The CAS Registry Mumber 25343-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,3,4 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 25343-30:
(7*2)+(6*5)+(5*3)+(4*4)+(3*3)+(2*3)+(1*0)=90
90 % 10 = 0
So 25343-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H16N2S/c1-3-8-6-5-7-9(4-2)10(8)13-11(12)14/h5-7H,3-4H2,1-2H3,(H3,12,13,14)
25343-30-0Relevant academic research and scientific papers
OPIOID RECEPTOR MODULATORS AND USE THEREOF
-
Paragraph 0048; 0185; 0186; 0187, (2017/03/21)
Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method
Novel synthetic approach to N-aryl-4-(3-pyridyl)thiazol-2-amine and analogues using HMCM-41 as catalyst, and their biological evaluation as human platelet aggregation inhibitors
Bhoga, Umadevi
, p. 1144 - 1150 (2008/03/12)
A novel synthetic approach to N-aryl-4-(3-pyridyl)thiazol-2-amine and analogues using HMCM-41, a mesoporous aluminosilicate catalyst and their in vitro ADP-induced platelet aggregation inhibitory activity on human blood platelets is described. Among the test compounds N-(2′-flourophenyl)-4-(3-pyridyl)thiazol-2-amine (9e) was found to be the most potent, IC50 = 4.84 × 10-7 M.